AAPACN 2025 Quality Virtual Conference Recording Bundle: Novice Track-1.3 Staying on Track: Managing Section N, Medications

Video Transcription

Video Summary

This comprehensive presentation emphasizes the critical importance of accurate Minimum Data Set (MDS) coding in skilled nursing facilities, focusing on Section N related to medication use. Accurate MDS coding impacts reimbursement, regulatory compliance, care planning, and quality outcomes. Key points include the importance of monitoring high-risk medications such as antipsychotics, opioids, anticoagulants, and insulin, especially given the vulnerability of elderly residents due to physiological changes and polypharmacy risks.<br /><br />The session outlines coding requirements for documenting injections, insulin use and changes, high-risk drug classes, and gradual dose reductions (GDRs) of antipsychotics, which must be tracked meticulously. It stresses the necessity of thorough physician documentation for medication indication, administration, and responses, including clear communication with prescribers and proper infection control practices.<br /><br />Quality measures associated with medication use, such as short- and long-stay antipsychotic measures, and exclusions for diagnoses like schizophrenia, are explained. The presentation highlights regulatory requirements for drug regimen reviews (DRRs), focusing on identifying and addressing clinically significant medication issues through timely two-way communication and interventions.<br /><br />Care planning should integrate medication indications, side effects, monitoring strategies, and non-pharmacological interventions. Facilities are urged to educate staff on medication classifications and side effects to prevent errors and citations. Overall, the session promotes coordinated, vigilant medication management to enhance patient safety, quality of care, and compliance in long-term care settings.

Keywords

Minimum Data Set (MDS) coding

Section N medication use

skilled nursing facilities

high-risk medications

antipsychotics monitoring

opioids and anticoagulants

insulin management

drug regimen reviews (DRRs)

medication safety and compliance